Great post Robert. In addition ... One major method of lowering exponentially increasing healthcare costs is the early detection and management of diseases. It is much less expensive to detect disease in its early stages through imaging than paying for long-term treatments. Not to mention that it obviously improves quality of life. Sooner or later, the market will recognize the increasing importance of imaging, and Positron's role in that market (if they deliver as expected). I have no doubt that Positron's share price will quickly increase with a positive material announcement.